Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
PIKfyve inhibitor
DRUG CLASS:
PIKfyve inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
HZX-02-059 (2)
HZX-02-059 (2)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
MYC rearrangement + BCL6 rearrangement
Lymphoma
MYC rearrangement + BCL6 rearrangement
Lymphoma
HZX-02-059
Sensitive: D – Preclinical
HZX-02-059
Sensitive
:
D
HZX-02-059
Sensitive: D – Preclinical
HZX-02-059
Sensitive
:
D
MYC rearrangement + BCL2 rearrangement
Lymphoma
MYC rearrangement + BCL2 rearrangement
Lymphoma
HZX-02-059
Sensitive: D – Preclinical
HZX-02-059
Sensitive
:
D
HZX-02-059
Sensitive: D – Preclinical
HZX-02-059
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.